Skip to main content

UBS Group AG

Position in XLO — Xilio Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in XLO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$33,958
+$33,829 QoQ
Shares Held
4,038
+1889.2% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. XLO ranks #408 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XLO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $33,958 4,038
2025-12-31 $129 203
2025-09-30 $11,507 13,652
2025-06-30 $163,178 239,969
2025-03-31 $118,085 163,101
2024-12-31 $238,177 249,401
2024-09-30 $12,397 15,733
2024-06-30 $190 201
2024-03-31 $217 201
2023-12-31 $110 201
2023-09-30 $424 201
2023-06-30 $526 201
2023-03-31 $637 201
2022-12-31 $540 201
2022-09-30 $584 201
2022-06-30 $8,215 2,814
2022-03-31 $6,815 964
2021-12-31 $63,630 3,977